Condition
Cerebellar Diseases
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.9% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed2
Recruiting1
Terminated1
Unknown1
Trial Success Rate
66.7%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07642856Not ApplicableRecruiting
Individualized Neuro-Modulation Paired With Cerebellar Therapy
NCT00266760Completed
Characteristics of Episodic Ataxia Syndrome
NCT05024240Not ApplicableUnknown
Interaction of the Cognitive and Sensory-cognitive Tasks With Postural Stability in Individuals With Stability Disorders
NCT03769961Terminated
Ataxia in Essential Tremor: Describing the Differences Between Disease Process and Treatment Effect
NCT02106819CompletedPrimary
Emotional Communication Disorders in Cerebellar Disease
Showing all 5 trials